PROF
PROF
NASDAQ · Health Care

Profound Medical Corp

$6.97
-0.23 (-3.19%)
Financial Highlights (FY 2026)
Revenue
26.76M
Net Income
-70,769,037
Gross Margin
70.8%
Profit Margin
-264.4%
Rev Growth
+34.1%
D/E Ratio
0.07
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 70.8% 70.8% 58.7% 58.7%
Operating Margin -256.3% -230.6% 13.1% 12.1%
Profit Margin -264.4% -251.2% 10.1% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 26.76M 19.96M 110.97M 130.03M
Gross Profit 18.94M 14.13M 65.14M 76.33M
Operating Income -68,584,686 -46,043,724 14.49M 15.72M
Net Income -70,769,037 -47,510,169 11.22M 17.35M
Gross Margin 70.8% 70.8% 58.7% 58.7%
Operating Margin -256.3% -230.6% 13.1% 12.1%
Profit Margin -264.4% -251.2% 10.1% 13.3%
Rev Growth +34.1% +34.1% +15.1% +0.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 11.31M 11.31M 159.28M 166.07M
Total Equity 167.10M 167.10M 201.01M 174.26M
D/E Ratio 0.07 0.07 0.79 0.95
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -67,959,585 -48,158,739 16.88M 21.68M
Free Cash Flow 17.89M 15.74M